Drugmaker GlaxoSmithKline has a history of abusing the system in order to maintain monopolies on its products and keep prices high for patients.
The drug giant is cutting pay-for-delay deals, filing frivolous lawsuits, and setting prices out of reach. Patients with diseases like lupus, asthma, and COPD are suffering while GSK is padding its profit margins.
We’re collecting stories from patients who have been affected by high-priced drugs from GSK, including:
- Breo Ellipta
- Trilogy Ellipta
Help us hold GlaxoSmithKline accountable –– record a video and share your story today!
Not sure how to start? Here are examples we’ve heard from real patients:
“Because of the high price of Breo, I skip doses, which makes it harder for me to breathe. Sometimes my whole body starts hurting.”
“Trelegy Ellipta is a medicine that is the difference between living and dying for me. It opens up my airways so that I can breathe better, and GlaxoSmithKline threatens that by charging such high prices.”